Effect of PVP K30 and/or l-Arginine on Stability Constant of Etoricoxib-HPβCD Inclusion Complex: Preparation and Characterization of Etoricoxib-HPβCD Binary System.

MLA

Shah, Manali, et al. “Effect of PVP K30 and/or l-Arginine on Stability Constant of Etoricoxib-HPβCD Inclusion Complex: Preparation and Characterization of Etoricoxib-HPβCD Binary System.” Drug Development & Industrial Pharmacy, vol. 35, no. 1, Jan. 2009, pp. 118–29. EBSCOhost, https://doi.org/10.1080/03639040802220292.

APA

Shah, M., Karekar, P., Sancheti, P., Vyas, V., & Pore, Y. (2009). Effect of PVP K30 and/or l-Arginine on Stability Constant of Etoricoxib-HPβCD Inclusion Complex: Preparation and Characterization of Etoricoxib-HPβCD Binary System. Drug Development & Industrial Pharmacy, 35(1), 118–129. https://doi.org/10.1080/03639040802220292

Chicago

Shah, Manali, Poonam Karekar, Pankajkumar Sancheti, Vikrant Vyas, and Yogesh Pore. 2009. “Effect of PVP K30 and/or l-Arginine on Stability Constant of Etoricoxib-HPβCD Inclusion Complex: Preparation and Characterization of Etoricoxib-HPβCD Binary System.” Drug Development & Industrial Pharmacy 35 (1): 118–29. doi:10.1080/03639040802220292.